Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.

BACKGROUND Hepatitis C virus (HCV) genotype is an important determinant of virological response to antiviral therapies. Currently, there are no data available on the molecular epidemiology and interferon susceptibility of the natural intergenotypic recombinant RF1_2k/1b (RF1) strain. METHODS Genotyping and RF1-PCR screening were performed on samples from 604 HCV RNA-positive individuals from 7 countries. uPA/SCID mice carrying human hepatocytes (chimeric mice) were infected with the RF1_2k/1b strain, and the susceptibility of the strain to interferon and ribavirin was compared with the susceptibilities of 2 different strains of genotype B, used as references. RESULTS Six new RF1 cases were identified in this study; 5 (2%) of 281 in Russia and 1 (1%) of 90 in Uzbekistan. Phylogenetic analyses based on Core/E1 and NS5b indicated that all RF1 representatives share a common evolutionary ancestor. Infection with RF1 was established in chimeric mice. Reduction of RF1 viral load was observed in response to 3 injections of 3 microg/kg pegylated-interferon alpha-2a alone or in combination with 50 mg/kg of ribavirin (0.5 or 1.4 log-copies/mL). CONCLUSIONS All identified RF1-type strains appear to be introduced from a single source, suggesting that intergenotypic recombination in HCV is sporadic and not associated with cocirculation of different genotypes in a population. The RF1 strain in this study was responsive to interferon in vivo.

[1]  F. Sugauchi,et al.  Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  Yoshio Tateno,et al.  Development and public release of a comprehensive hepatitis virus database , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  A. Moya,et al.  Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment , 2008, Journal of medical virology.

[4]  T. Krispin,et al.  Genetic characterization of hepatitis C virus strains in Estonia: Fluctuations in the predominating subtype with time , 2007, Journal of medical virology.

[5]  S. Kuge,et al.  Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice. , 2007, Biochemical and biophysical research communications.

[6]  D. Gretch,et al.  Molecular diagnostics of hepatitis C virus infection: a systematic review. , 2007, JAMA.

[7]  J. Blackard,et al.  Hepatitis C virus coinfection and superinfection. , 2007, The Journal of infectious diseases.

[8]  Ralf Bartenschlager,et al.  Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes , 2007, Journal of Virology.

[9]  Christopher T. Jones,et al.  Superinfection Exclusion in Cells Infected with Hepatitis C Virus , 2007, Journal of Virology.

[10]  C. Pasquier,et al.  New Natural Intergenotypic (2/5) Recombinant of Hepatitis C Virus , 2007, Journal of Virology.

[11]  C. Pasquier,et al.  Genetic diversity of HCV genotype 2 strains in South Western France , 2007, Journal of medical virology.

[12]  I. Moreau,et al.  Serendipitous identification of natural Intergenotypic recombinants of hepatitis C in Ireland , 2006, Virology Journal.

[13]  A. Ambrozaitis,et al.  Characterization of HCV strains in an oncohematological pediatric department reveals little horizontal transmission but multiple introductions by un‐screened blood products in the past , 2006, Journal of medical virology.

[14]  H. Ichimura,et al.  A natural inter‐genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines , 2006, Journal of medical virology.

[15]  D. Casane,et al.  Evidence of recombination in quasispecies populations of a Hepatitis C Virus patient undergoing anti-viral therapy , 2006, Virology Journal.

[16]  C. Arnold,et al.  Multitypic Hepatitis C Virus Infection Identified by Real-Time Nucleotide Sequencing of Minority Genotypes , 2006, Journal of Clinical Microbiology.

[17]  A. Osterhaus,et al.  Identification of a Naturally Occurring Recombinant Genotype 2/6 Hepatitis C Virus , 2006, Journal of Virology.

[18]  Christophe Combet,et al.  Hepatitis C databases, principles and utility to researchers , 2006, Hepatology.

[19]  S. Mano,et al.  Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. , 2006, Gastroenterology.

[20]  B. Robertson,et al.  Molecular epidemiology of the hepatitis C virus in Western Siberia , 2005, Journal of medical virology.

[21]  Christophe Combet,et al.  Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes , 2005, Hepatology.

[22]  Yoshiyuki Suzuki,et al.  Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy , 2005, Intervirology.

[23]  T. Roskams,et al.  Morphological and biochemical characterization of a human liver in a uPA‐SCID mouse chimera , 2005, Hepatology.

[24]  O. Pybus,et al.  Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. , 2004, The Journal of infectious diseases.

[25]  T. Asahara,et al.  Near completely humanized liver in mice shows human-type metabolic responses to drugs. , 2004, The American journal of pathology.

[26]  O. Kalinina,et al.  Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation. , 2004, The Journal of general virology.

[27]  F. Sugauchi,et al.  Hepatitis C virus molecular epidemiology in Uzbekistan , 2003, Journal of medical virology.

[28]  T. Gojobori,et al.  A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Olga Kalinina,et al.  A Natural Intergenotypic Recombinant of Hepatitis C Virus Identified in St. Petersburg , 2002, Journal of Virology.

[30]  O. Pybus,et al.  The Epidemic Behavior of the Hepatitis C Virus , 2001, Science.

[31]  O. Pybus,et al.  An integrated framework for the inference of viral population history from reconstructed genealogies. , 2000, Genetics.

[32]  R. Kawaguchi,et al.  Real-time detection system for quantification of hepatitis C virus genome. , 1999, Gastroenterology.

[33]  M. Mizokami,et al.  New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a , 1997, Journal of clinical microbiology.

[34]  K. Chayama,et al.  Typing six major hepatitis C virus genotypes by polymerase chain reaction using primers derived from nucleotide sequences of the NS5 region , 1996 .

[35]  N Enomoto,et al.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.

[36]  M. Hijikata,et al.  Full-genome Nucleotide Sequence of a Hepatitis C Virus Variant (Isolate Name VAT96) Representing a New Subtype within the Genotype 2 (Arbitrarily 2k) , 2004, Virus Genes.

[37]  H. Romero,et al.  Evidence of intratypic recombination in natural populations of hepatitis C virus. , 2004, The Journal of general virology.

[38]  M. Mondelli,et al.  Clinical significance of hepatitis C virus genotypes. , 1999, Journal of hepatology.